Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer

af Halmos, Balazs, Pennell, Nathan A., Fu, Pingfu, Saad, Shumaila, Gadgeel, Shirish, Otterson, Gregory A., Mekhail, Tarek, Snell, Michael, Kuebler, J. Philip, Sharma, Neelesh, Dowlati, Afshin
Udgivet i Oncologist (2015)

Phase I Trial of Fludarabine, Bortezomib and Rituximab for Relapsed and Refractory Indolent and Mantle Cell Non-Hodgkin Lymphoma

af Barr, Paul M., Fu, Pingfu, Lazarus, Hillard M., Horvath, Nancy, Gerson, Stanton L., Koc, Omer N., Bahlis, Nizar J., Snell, Michael R., Dowlati, Afshin, Cooper, Brenda W.
Udgivet 2009